NeurAegis, Inc.

About:

NeurAegis is a privately held pharmaceutical company pioneering the development of breakthrough treatments for neurological disorders.

Website: https://www.neuraegis.com

Top Investors: Combat Casualty Care Research Program

Description:

NeurAegis is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders. Founded in 2016, our initial focus is developing first-in-class, novel protease inhibitors for mild traumatic brain injury (concussion) where there are currently no FDA approved treatments.

Total Funding Amount:

$3.8M

Headquarters Location:

Irvine, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)neuraegis.com

Founders:

Joseph Blanchard, MBA, Michel Baudry, PhD, Michel Baudry, PhD

Number of Employees:

1-10

Last Funding Date:

2019-09-05

IPO Status:

Private

Industries: